GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Inventories, Raw Materials & Components

Noile-Immune Biotech (TSE:4893) Inventories, Raw Materials & Components : 円16.6 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Inventories, Raw Materials & Components?

Noile-Immune Biotech's inventories, raw materials & components for the quarter that ended in Mar. 2024 was 円16.6 Mil.

Noile-Immune Biotech's quarterly raw materials declined from Sep. 2023 (円22.6 Mil) to Dec. 2023 (円20.9 Mil) and declined from Dec. 2023 (円20.9 Mil) to Mar. 2024 (円16.6 Mil).

Noile-Immune Biotech's annual raw materials declined from Dec. 2021 (円4.3 Mil) to Dec. 2022 (円3.9 Mil) but then increased from Dec. 2022 (円3.9 Mil) to Dec. 2023 (円20.9 Mil).


Noile-Immune Biotech Inventories, Raw Materials & Components Historical Data

The historical data trend for Noile-Immune Biotech's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Inventories, Raw Materials & Components Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
3.90 4.27 3.93 20.90

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only - 8.17 22.59 20.90 16.58

Noile-Immune Biotech Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Noile-Immune Biotech (TSE:4893) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines